Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer J Anderson

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Health Services Research|September 19, 2002
Diagnostic cost groups (DCGs) and concurrent utilization among patients with substance abuse disordersAmy K Rosen, Susan A Loveland, Jennifer J Anderson, et al.
Blood|August 24, 2006
Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65David C Seldin, Jennifer J Anderson, Martha Skinner, et al.
Arthritis and Rheumatism|July 29, 2006
Durometry for the assessment of skin disease in systemic sclerosisEugene Y Kissin, Aileen M Schiller, Rondi B Gelbard, et al.
Journal of Pediatric Urology|June 18, 2013
Analysis of an intervention to reduce parental anxiety prior to voiding cystourethrogramLisa L Lachenmyer, Jennifer J Anderson, Douglass B Clayton, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 1, 2003
Beta 2 microglobulin serum levels and prediction of survival in AL amyloidosisCristiano A F Zerbini, Jennifer J Anderson, Kelly A Kane, et al.
The Journal of Rheumatology|July 15, 2003
Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteriaThao Pham, Désirée Van Der Heijde, Marissa Lassere, et al.
Blood|May 25, 2004
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantationDavid C Seldin, Jennifer J Anderson, Vaishali Sanchorawala, et al.
Health Services Research|March 26, 2003
Quality improvement implementation in the nursing homeDan R Berlowitz, Gary J Young, Elaine C Hickey, et al.
Annals of Internal Medicine|January 22, 2004
High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year studyMartha Skinner, Vaishali Sanchorawala, David C Seldin, et al.
Arthritis and Rheumatism|October 2, 2002
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenonPeter A Merkel, Karen Herlyn, Richard W Martin, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Health Services Research|September 19, 2002
Diagnostic cost groups (DCGs) and concurrent utilization among patients with substance abuse disordersAmy K Rosen, Susan A Loveland, Jennifer J Anderson, et al.
Blood|August 24, 2006
Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65David C Seldin, Jennifer J Anderson, Martha Skinner, et al.
Arthritis and Rheumatism|July 29, 2006
Durometry for the assessment of skin disease in systemic sclerosisEugene Y Kissin, Aileen M Schiller, Rondi B Gelbard, et al.
Journal of Pediatric Urology|June 18, 2013
Analysis of an intervention to reduce parental anxiety prior to voiding cystourethrogramLisa L Lachenmyer, Jennifer J Anderson, Douglass B Clayton, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 1, 2003
Beta 2 microglobulin serum levels and prediction of survival in AL amyloidosisCristiano A F Zerbini, Jennifer J Anderson, Kelly A Kane, et al.
The Journal of Rheumatology|July 15, 2003
Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteriaThao Pham, Désirée Van Der Heijde, Marissa Lassere, et al.
Blood|May 25, 2004
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantationDavid C Seldin, Jennifer J Anderson, Vaishali Sanchorawala, et al.
Health Services Research|March 26, 2003
Quality improvement implementation in the nursing homeDan R Berlowitz, Gary J Young, Elaine C Hickey, et al.
Annals of Internal Medicine|January 22, 2004
High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year studyMartha Skinner, Vaishali Sanchorawala, David C Seldin, et al.
Arthritis and Rheumatism|October 2, 2002
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenonPeter A Merkel, Karen Herlyn, Richard W Martin, et al.
Pageof 3